Your session is about to expire
← Back to Search
NET + MIST for HIV Prevention and Substance Use Disorders
N/A
Recruiting
Led By Debra Kaysen, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
16 years old or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post intervention; baseline and 3-month follow up; baseline and 6-month follow up
Awards & highlights
Study Summary
This trial will compare two programs designed to lower HIV sexual-risk behaviors in American Indian / Alaska Native men and women. One program focuses on addressing PTSD as a way to prevent substance use disorders and HIV sexual-risk behaviors, while the other program focuses on addressing substance misuse as a way to prevent these disorders.
Who is the study for?
This trial is for Native American men and women who are at least 16 years old, have been sexually active, used substances in the past year, and have some PTSD symptoms. It's not for those with recent severe suicidal or homicidal thoughts, unstable psychiatric meds, or severe alcohol withdrawal.Check my eligibility
What is being tested?
The study compares two programs designed to reduce HIV risk behaviors by addressing trauma and substance use: Narrative Exposure Therapy (NET) focuses on treating PTSD while Motivational Interviewing with Skills Training (MIST) targets substance misuse.See study design
What are the potential side effects?
While specific side effects aren't listed for these psychological interventions, participants may experience emotional discomfort when discussing traumatic events or confronting substance use issues during therapy sessions.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 16 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and post intervention; baseline and 3-month follow up; baseline and 6-month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post intervention; baseline and 3-month follow up; baseline and 6-month follow up
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Drug Use as assessed by PhenX Toolkit
Change in PTSD symptoms as assessed by the Posttraumatic Symptom Scale Interview Diagnostic and Statistical Manual 5th Ed (DSM-5) (PSSI5)
National Institute on Drug Abuse (NIDA) Seek, Test, Treat and Retain for Vulnerable Populations: Data Harmonization Measure
Trial Design
2Treatment groups
Experimental Treatment
Group I: Narrative Exposure Therapy (NET)Experimental Treatment1 Intervention
Counseling program
Group II: Motivational Interviewing w/Skills Training (MIST)Experimental Treatment1 Intervention
Counseling program
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Narrative Exposure Therapy (NET)
2014
N/A
~60
Find a Location
Who is running the clinical trial?
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,011 Total Patients Enrolled
University of WashingtonLead Sponsor
1,740 Previous Clinical Trials
1,847,470 Total Patients Enrolled
Debra Kaysen, PhDPrincipal InvestigatorUniversity of Washington
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had sexual activity at some point in my life.My psychiatric medication has been stable for less than 2 months.You are a member of a Native American tribe.You have had thoughts of hurting or killing someone in the past 3 months.You have symptoms of post-traumatic stress disorder (PTSD), even if they are not severe enough to meet the full diagnosis.You have used drugs within the last 12 months.You have had thoughts of suicide, made plans for suicide, or attempted suicide in the past 30 days.I am 16 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Narrative Exposure Therapy (NET)
- Group 2: Motivational Interviewing w/Skills Training (MIST)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this medical study currently seeking participants?
"Affirmative. According to the data sourced from clinicaltrials.gov, this medical investigation is still actively recruiting candidates and was first posted on September 21st 2017. 200 patients are required for the study that will be conducted at one site."
Answered by AI
How many participants are included in the current research protocol?
"Affirmative. The clinical trial's listing on the online database, clinicaltrials.gov, verifies that it is actively seeking participants as of June 28th 2022. This research opportunity was initially available to patients since September 21st 2017 and requires 200 enrollees from 1 medical centre."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger